Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Print Material
Author Ahn, Hyewon.

Title Patentability of chemical selection inventions : the Olanzapine and Escitalopram decisions / Hyewon Ahn.

Publication Info. Baden-Baden : Nomos, 2011.

Copies

Location Call No. OPAC Message Status
 Axe JSTOR Open Ebooks  Electronic Book    ---  Available
Edition First edition.
Description 1 online resource (75 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
data file
Legal case and case notes
Note Originally presented as the author's thesis--Universität München, 2010.
Bibliography Includes bibliographical references (pages 69-75).
Contents Introduction -- Background -- Jurisprudence on the patentability requirements for selection inventions -- Discussion -- Conclusion.
Note Print version record.
Summary The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions. This thesis provides an overview on the technology and patenting practice, followed by the discussion of jurisprudence on the patentability requirements for selection inventions in major jurisdictions. In particular, the paper examines the novelty and the non-obviousness requirements. As the discussion on the anticipation and obviousness is more contentious in selection inventions, this discusses the issues in view of the two decisions. Post grant impact of selection inventions and their meanings to the system of patent are explored, and some comparative perspectives on selection inventions are discussed. In conclusion, by exploring the significance of granting patents on selection invention to the working of patent system, this paper aims to provide a useful analysis in understanding patentability requirements thereof, beyond the pharmaceutical industry sector. The author researches on improvement patents in the field of pharmaceutical industry at the Max-Planck Institute in Munich.
Subject Drugs -- Patents.
Patent laws and legislation -- Cases.
Conflict of laws -- Patents -- Cases.
Drug development.
Olanzapine.
Citalopram
Médicaments -- Brevets d'invention.
Brevets d'invention (Droit international privé) -- Jurisprudence.
Médicaments -- Développement.
Olanzapine.
LAW -- Commercial -- General.
Conflict of laws -- Patents. (OCoLC)fst00874964
Drug development. (OCoLC)fst00898670
Drugs. (OCoLC)fst00898761
Olanzapine. (OCoLC)fst01045171
Patent laws and legislation. (OCoLC)fst01054823
Patentfähigkeit
Enantiomere
Wirkstoff
Deutschland.
Genre/Form Patents. (OCoLC)fst01423842
Trials, litigation, etc. (OCoLC)fst01423712
Other Form: Print version: Ahn, Hyewon. Patentability of chemical selection inventions. First edition. Baden-Baden : Nomos, 2011 9783832965242 (DLC) 2012474049 (OCoLC)719426677
ISBN 9783845232188 (electronic bk.)
3845232188 (electronic bk.)
9783832965242
3832965246
Standard No. AU@ 000065058830
AU@ 000065197610
AU@ 000068069011

 
    
Available items only